Compare · NBIS vs TEM
NBIS vs TEM
Side-by-side comparison of Nebius Group N.V. (NBIS) and Tempus AI Inc. (TEM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both NBIS and TEM operate in Computer Software: Programming Data Processing (Technology), so they compete in similar markets.
- NBIS is the larger of the two at $36.79B, about 3.7x TEM ($9.87B).
- Over the past year, NBIS is up 550.0% and TEM is up 1.8% - NBIS leads by 548.3 points.
- TEM has been more active in the news (12 items in the past 4 weeks vs 7 for NBIS).
- TEM has more recent analyst coverage (25 ratings vs 14 for NBIS).
PerformanceNBIS+550.04%TEM+1.76%
2025-05-05+0.00%2026-05-01
- Company
- Nebius Group N.V.
- Tempus AI Inc.
- Price
- $154.05+11.43%
- $55.01-0.80%
- Market cap
- $36.79B
- $9.87B
- 1M return
- +51.45%
- +17.07%
- 1Y return
- +550.04%
- +1.76%
- Industry
- Computer Software: Programming Data Processing
- Computer Software: Programming Data Processing
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2011
- 2024
- News (4w)
- 7
- 12
- Recent ratings
- 14
- 25
Latest NBIS
- Nebius Group Announces Date of First Quarter 2026 Results and Conference Call
- Nebius Agrees to Acquire Eigen AI, Strengthening Nebius Token Factory as a Frontier Inference Platform
- SEC Form 20-F filed by Nebius Group N.V.
- SEC Form 4 filed by Boroditsky Marc
- TD SYNNEX Expands AI Infrastructure-as-a-Service Portfolio with Dedicated NVIDIA HGX™ B300 Clusters on Nebius AI Cloud
- Wolfe Research initiated coverage on Nebius Group N.V.
- SEC Form 4 filed by Bunina Elena
- Cantor Fitzgerald initiated coverage on Nebius Group N.V. with a new price target
- SEC Form 4 filed by Korolenko Andrey
- SEC Form 4 filed by Volozh Arkadiy
Latest TEM
- CEO and Chairman Lefkofsky Eric P sold $8,500,623 worth of shares (166,250 units at $51.13) as part of a pre-agreed trading plan (SEC Form 4)
- Tempus to Host Inaugural Investor Day on May 29, 2026
- SEC Form 144 filed by Tempus AI Inc.
- Tempus Named to TIME's 10 Most Influential Health and Life Science Companies of 2026
- Median Technologies Reports Full-Year 2025 Financial Results and Provides Key Q1 2026 Business Highlights
- Tempus and USC Announce Strategic Collaboration to Accelerate AI-Driven Precision Medicine
- Tempus to Report First Quarter 2026 Financial Results on May 5
- Tempus and Predicta Biosciences Announce Collaboration to Expand Life Sciences Access to Ultrasensitive Whole-Genome Sequencing Assay for Hematologic Malignancies and MRD Monitoring
- Tempus Announces 31 Abstracts for Presentation at the American Association for Cancer Research Annual Meeting 2026
- Jefferies initiated coverage on Tempus AI with a new price target